BioSpace News Archive

Enhanced birth rates arising out of high fertility incidence is promoting more investments in infant and women’s health, including breastfeeding programs, enhancing growth prospects

Emerging economies across the Asia-Pacific and Africa are expected to emerge as key investment destinations for key giants

Application of sericin will remain high in personal care industry. This trend will continue due to the increasing demand for bio-based products in the industry.

According to the report, the global disinfectants market was valued over US$ 6.9 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

According to the report, the global downstream processing market was valued over US$ 6.7 Bn in 2019. It is projected to expand at a rapid pace from 2020 to 2030.

According to the report, the global hyperthermia cancer treatment market was valued at ~US$ 155 Mn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030.

According to the report, the global radiation proctitis market was valued at US$ 370 Mn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

Methicillin Resistant Staphylococcus aureus is the most prevalent multi-drug resistant bacteria and a growing threat to health.

Transdermal and transmucosal drug delivery systems as alternative drug delivery routes have gained traction in clinical practices over the past few decades.

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM in advanced clinical development to treat severe COVID-19 patients, announced that it has entered into a definitive agreement with a single healthcare-dedicated U.S. institutional investor to purchase in a private placement 41,459,370 of Relief common stock at a purchase price of CHF 0.2412 per share.